A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results.

Bracarda, Sergio

Bensfia, Samira

Ecstein-Fraisse, Evelyne B.

Heidenreich, Axel

Ozguroglu, Mustafa

Bavbek, Sevil E.

Malik, Zafar I.

Di Lorenzo, Giuseppe

Scholz, Hans-Jorg

van Oort, Inge M.

Siobhan Ng, Siobhan Ng

Gerritsen, Winald R.

Mueller, Stefan

Marttila, Timo

Aparicio, Luis M. Anton

Albers, Peter

Gschwend, Juergen E.